94 patients with more than 50% obstruction of the left main coronary artery (LM) were studied between February 1972 and August 1975. 18 patients (19%) had one-vessel disease; 21 (22%) two-vessel disease; and 52 (55%) three-vessel disease in addition to LM disease. Only 3 patients (3.1%) had solitary involvement of the LM, 38 (40%) presented a clinical picture of accelerated or recent onset of angina pectoris, and 56 patients (60%) had moderate to severe stable angina pectoris. By means of cinefluoroscopy, calcification was seen in 23 patients (24%). The resting electrocardiogram (ECG) was normal in only 5 patients (5.3%); in 55 patients (58%), the resting ECG showed nonspecific ST-T changes, and in 34 (36%) it showed evidence of an old infarction. Treadmill exercise electrocardiography was performed in 9 patients; the ECG was markedly positive in 7. Atrial pacing produced angina pectoris and ECG changes or an increase in left ventricular end-diastolic pressure (LVEDP) accompanied by a decrease in stroke work in 17 of 18 patients (94%). The left ventriculogram was normal in 18 patients (19%); in 76 patients (81%) it showed variable degrees of hypokinesia or dyskinesia, or both. The LVEDP was normal (12 mm Hg or less) in 41 patients (44%) and between 12 and 20mmHg in 33 patients (35%); in 20 (21%) it was higher than 20mmHg. Of these 20 patients with markedly elevated LVEDP, 16 had markedly abnormal ventriculograms, and were not considered candidates for surgery. In contrast to our earlier experience, there was no morbidity or mortality associated with cardiac catheterization. 54 patients (57%) underwent saphenous vein bypass surgery, with an operative mortality of 9 patients (17%). We concluded from the follow-up of our patients and our review of the literature that surgery offers symptomatic relief superior to that with medical therapy. However, the question of whether surgery prolongs life is not yet answered, and certainly further studies are needed.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.